{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:09:01Z","timestamp":1788930541979,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Drug discovery remains constrained by high attrition rates, prolonged timelines, and limited ability to translate molecular insights into effective therapies. Although reductionist approaches targeting individual molecules have delivered transformative medicines, successful patient-centric treatment remains a major challenge. Furthermore, increasing evidence demonstrates that therapeutic outcomes emerge from complex, dynamic, and context-dependent biological networks. Systems biology has provided a framework to understand these interactions, yet its predictive capability has been limited by biological complexity, incomplete mechanistic knowledge, and the predominance of associative omics data. Recent advances in artificial intelligence (AI), including machine learning, deep learning, and multimodal foundation models, now offer unprecedented opportunities to integrate increasingly large and heterogeneous biomedical datasets and uncover complex biological relationships. The convergence of AI with systems biology may provide a framework for developing mechanistically informed and testable predictive models that extend beyond target identification toward understanding disease mechanisms, therapeutic responses, and treatment failures. However, mechanistic integration should not be assumed to improve prediction universally. Its value must be evaluated against appropriately matched data-driven models under defined biological conditions. Ultimately, AI-driven systems biology approaches could contribute to the development of dynamic, patient-specific computational representations of biological systems, potentially accelerating precision medicine and transforming drug discovery from empirical experimentation toward predictive, mechanism-guided therapeutic design.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1954008","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:43:14Z","timestamp":1788928994000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Network biology to artificial intelligence: building the next generation of predictive drug discovery"],"prefix":"10.3389","volume":"17","author":[{"given":"Kumar","family":"Selvarajoo","sequence":"first","affiliation":[{"name":"Key Laboratory of Preclinical Research of Antitumor Drugs, Taizhou Institute of Zhejiang University","place":["Taizhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"B2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/d41573-024-00130-3","article-title":"Per-patient approach to calculating drug development costs yields lower estimate","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J Health Econ"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated research and development investment needed to bring a new medicine to market, 2009\u20132018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrg.2016.86","article-title":"Towards precision medicine","volume":"17","author":"Ashley","year":"2016","journal-title":"Nat Rev Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0030059","article-title":"The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics","volume":"3","author":"Yu","year":"2007","journal-title":"PloS Comp Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac229","article-title":"Network approaches for modeling the effect of drugs and diseases","volume":"23","author":"Rintala","year":"2022","journal-title":"Brief Bioinform"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-023-00063-3","article-title":"Human disease models in drug development","volume":"1","author":"L\u00f6wa","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa031766","article-title":"Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol","volume":"350","author":"Brousseau","year":"2004","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2008.02.014","article-title":"Effects of Torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.229","article-title":"Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating aldosterone","volume":"154","author":"Forrest","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2195","article-title":"A robustness-based approach to systems-oriented drug design","volume":"6","author":"Kitano","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2016.09.002","article-title":"The promises of quantitative systems pharmacology modelling for drug development","volume":"14","author":"Knight-Schrijver","year":"2016","journal-title":"Comput Struct Biotechnol J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/gr.190595.115","article-title":"Defining cell types and states with single-cell genomics","volume":"25","author":"Trapnell","year":"2015","journal-title":"Genome Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1543","article-title":"Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate","volume":"9","author":"Santos","year":"2007","journal-title":"Nat Cell Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mec.2020.e00149","article-title":"Systems biology approaches integrated with artificial intelligence for optimized metabolic engineering","volume":"11","author":"Helmy","year":"2020","journal-title":"Metab Eng Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142502","article-title":"Getting closer to the whole picture","volume":"316","author":"Sauer","year":"2007","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/msb.2011.99","article-title":"Differential network biology","volume":"8","author":"Ideker","year":"2012","journal-title":"Mol Sys Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac436","article-title":"Machine learning alternative to systems biology should not solely depend on data","volume":"23","author":"Yeo","year":"2022","journal-title":"Brief Bioinform"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbag127","article-title":"Are we ready for causal discovery in biological systems using deep learning","volume":"27","author":"Yeo","year":"2026","journal-title":"Brief Bioinform"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011916","article-title":"AI-Aristotle: A physics-informed framework for systems biology gray-box identification","volume":"20","author":"Ahmadi Daryakenari","year":"2024","journal-title":"PloS Comp Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c00340","article-title":"Application of machine learning and mechanistic modeling to predict intravenous pharmacokinetic profiles in humans","volume":"68","author":"Jia","year":"2025","journal-title":"J Med Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2026-0045","article-title":"Artificial intelligence as a computational kit for digital biomarker discovery","volume":"14","author":"Hong","year":"2026","journal-title":"J Transl Int Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.34133\/research.1224","article-title":"Artificial intelligence in traditional Chinese medicine: Unraveling herbal medicine's mechanisms","volume":"9","author":"He","year":"2026","journal-title":"Res (Wash D C)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.1038\/s41467-024-53742-z","article-title":"A molecular video-derived foundation model for scientific drug discovery","volume":"15","author":"Xiang","year":"2024","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1038\/s41467-023-39902-7","article-title":"Detecting shortcut learning for fair medical AI using shortcut testing","volume":"14","author":"Brown","year":"2023","journal-title":"Nat Comm"},{"key":"B35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41746-024-01118-4","article-title":"Shortcut learning in medical AI hinders generalization: method for estimating AI model generalization without external data","volume":"7","author":"Ong Ly","year":"2024","journal-title":"NPJ Digit Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05881-4","article-title":"Foundation models for generalist medical artificial intelligence","volume":"616","author":"Moor","year":"2023","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100864","DOI":"10.1016\/j.landig.2025.02.004","article-title":"Medical digital twins: enabling precision medicine and medical artificial intelligence","volume":"7","author":"Sad\u00e9e","year":"2025","journal-title":"Lancet Digit Health"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13073-019-0701-3","article-title":"Digital twins to personalize medicine","volume":"12","author":"Bj\u00f6rnsson","year":"2020","journal-title":"Genome Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s42256-019-0048-x","article-title":"Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead","volume":"1","author":"Rudin","year":"2019","journal-title":"Nat Mach Intell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2410.04585","DOI":"10.48550\/arXiv.2410.04585","article-title":"Reasoning-Enhanced healthcare predictions with knowledge graph community retrieval","author":"Jiang","year":"2024","journal-title":"arXiv"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/mdr2.70039","article-title":"RSA-KG: a graph-based RAG enhanced AI knowledge graph for recurrent spontaneous abortions diagnosis and clinical decision support","volume":"1","author":"He","year":"2025","journal-title":"Med Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0079-3","article-title":"Organs-on-chips: into the next decade","volume":"20","author":"Low","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2174\/0115734129333473241018114102","article-title":"Integrating organ-on-chip models in drug discovery: a comprehensive review on innovations and implications","volume":"20","author":"Seenivasan","year":"2025","journal-title":"Curr Pharm Anal"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00031","article-title":"Digital twins in health care: ethical implications of an emerging engineering paradigm","volume":"9","author":"Bruynseels","year":"2018","journal-title":"Front Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpan.2025.09.001","article-title":"Network pharmacology, molecular docking, and molecular dynamics simulation in drug development: a comprehensive perspective","volume":"21","author":"Liu","year":"2025","journal-title":"Curr Pharm Anal"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae300","article-title":"Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical data","volume":"25","author":"Rashid","year":"2024","journal-title":"Brief Bioinform"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.20517\/jtgg.2025.108","article-title":"Translational insights into Duchenne muscular dystrophy: network biomarker identification and drug repositioning through multi-omics approaches","volume":"9","author":"Aydin","year":"2025","journal-title":"J Transl Genet Genom"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/srep00144","article-title":"Enhancing apoptosis in TRAIL-resistant cancer cells using fundamental response rules","volume":"2","author":"Piras","year":"2012","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1954008\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:43:32Z","timestamp":1788929012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1954008\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2026.1954008"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1954008","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"1954008"}}